Packed red cell transfusions in preterm neonates: a retrospective study
Main Article Content
Keywords
hyaline membrane disease, preterm neonates, red cell transfusion, respiratory distress syndrome
Abstract
Introduction: Preterm neonates are highly vulnerable to anemia. Packed red cell (PRC) transfusions are often necessary but must be carefully considered due to associated risks. This study aims to assess the characteristics of preterm infants who received PRC transfusions to guide safer and effective transfusion practices.
Methods: This study was conducted using a retrospective descriptive approach. It included preterm neonates who received PRC transfusions, as documented in the medical records from July 2022 to March 2025. Patient characteristics, hemoglobin level, transfusion profile, and comorbidities in preterm neonates receiving PRC transfusions were evaluated.
Results: The sample consisted of 52 neonates, 37 boys, and 15 girls. The gestational age of infants was mainly between 28 and <32 weeks (64,5%). Most neonates were very low birth weight, which is 53,8%. The mode of delivery was relatively similar between spontaneously and cesarean section. The average length of hospital stay was 35.27 ± 16.62 days. The initial hemoglobin level of preterm infants receiving PRC transfusions averaged 10.88 ± 1.33 g/dL. The first transfusion was typically administered at 18.10 ± 9.69 days of life. Notably, most infants (59.6%) required three or fewer transfusions. The most common comorbidity among preterm infants receiving PRC transfusions was respiratory distress syndrome (RDS) at 78.8%, followed by neonatal jaundice (53.8%) and asphyxia (40.4%). Most RDS cases (69.2%) were caused by hyaline membrane disease (HMD).
Conclusion: Preterm neonates receiving PRC transfusions had a high-risk profile, underscoring the importance of individualized transfusion thresholds and close post-transfusion monitoring to improve clinical outcomes.
References
2. Simhan HN. Preterm Labor [Internet]. Protocols for High‐Risk Pregnancies. Wiley; 2020. p. 443–8. Available from: http://dx.doi.org/10.1002/9781119635307.ch43
3. Khandre V, Potdar J, Keerti A. Preterm Birth: An Overview. Cureus. 2022;14(12):e33006. Available from: http://dx.doi.org/10.7759/cureus.33006
4. Kitaoka H, Shitara Y, Kashima K, Ochiai S, Chikai H, Watanabe K, et al. Risk factors for anemia of prematurity among 30-35-week preterm infants. FUKUSHIMA J Med Sci. 2023;69(2):115–23. Available from: http://dx.doi.org/10.5387/fms.2022-21
5. Kalezi ZE, Kisenge R, Naburi H, Simbila AN, Mkony M, Leyna G. Prevalence of anaemia and associated factors among preterm infants at six weeks chronological age at Muhimbili National Hospital, Dar es Salaam, Tanzania: a cross-sectional study. Pan Afr Med J. 2023;44. Available from: http://dx.doi.org/10.11604/pamj.2023.44.193.31190
6. Holzapfel LF, Rysavy MA, Bell EF. Red Blood Cell Transfusion Thresholds for Anemia of Prematurity. Neoreviews. 2023;24(6):e370–6. Available from: http://dx.doi.org/10.1542/neo.24-6-e370
7. Cibulskis CC, Maheshwari A, Rao R, Mathur AM. Anemia of prematurity: how low is too low? J Perinatol. 2021;41(6):1244–57. Available from: http://dx.doi.org/10.1038/s41372-021-00992-0
8. Saito‐Benz M, Flanagan P, Berry MJ. Management of anaemia in pre‐term infants. Br J Haematol. 2019;188(3):354–66. Available from: http://dx.doi.org/10.1111/bjh.16233
9. Kirpalani H, Bell EF, Hintz SR, Tan S, Schmidt B, Chaudhary AS, et al. Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants. N Engl J Med. 2020;383(27):2639–51. Available from: http://dx.doi.org/10.1056/nejmoa2020248
10. Wang Y-C, Chan O-W, Chiang M-C, Yang P-H, Chu S-M, Hsu J-F, et al. Red Blood Cell Transfusion and Clinical Outcomes in Extremely Low Birth Weight Preterm Infants. Pediatr & Neonatol. 2017;58(3):216–22. Available from: http://dx.doi.org/10.1016/j.pedneo.2016.03.009
11. Franz AR, Engel C, Bassler D, Rüdiger M, Thome UH, Maier RF, et al. Effects of Liberal vs Restrictive Transfusion Thresholds on Survival and Neurocognitive Outcomes in Extremely Low-Birth-Weight Infants: The ETTNO Randomized Clinical Trial. JAMA. 2020;324(6):560–70. Available from: 10.1001/jama.2020.10690
12. Fontana C, Raffaeli G, Pesenti N, Boggini T, Cortesi V, Manzoni F, et al. Red blood cell transfusions in preterm newborns and neurodevelopmental outcomes at 2 and 5 years of age. Blood Transfus. 2022;20(1):40–9. Available from: 10.2450/2020.0207-20
13. Skubisz A, de Vries LS, Jansen SJ, van der Staaij H, Lopriore E, Steggerda SJ. Early red blood cell transfusion and the occurrence of intraventricular hemorrhage in very preterm infants. Early Hum Dev. 2024;189:105926. Available from: http://dx.doi.org/10.1016/j.earlhumdev.2023.105926
14. Widness JA. Pathophysiology of Anemia During the Neonatal Period, Including Anemia of Prematurity. Neoreviews. 2008;9(11):e520–5. Available from: http://dx.doi.org/10.1542/neo.9-11-e520
15. Andersen CC, Keir AK, Kirpalani HM, Stark MJ. Anaemia in the Premature Infant and Red Blood Cell Transfusion: New Approaches to an Age-Old Problem. Curr Treat Options Pediatr. 2015;1(3):191–201. Available from: http://dx.doi.org/10.1007/s40746-015-0021-9
16. Nassin ML, Lapping-Carr G, de Jong JLO. Anemia in the Neonate: The Differential Diagnosis and Treatment. Pediatr Ann. 2015;44(7). Available from: http://dx.doi.org/10.3928/00904481-20150710-08
17. Costescu OC, Boia ER, Boia M, Cioboata DM, Doandes FM, Lungu N, et al. The Role of Erythropoietin in Preventing Anemia in the Premature Neonate. Children. 2023;10(12):1843. Available from: http://dx.doi.org/10.3390/children10121843